CVE:PAS Pascal Biosciences (PAS) Stock Price, News & Analysis → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free PAS Stock Alerts C$0.02 -0.01 (-25.00%) (As of 12/5/2022) Add Compare Share Share Today's RangeC$0.02▼C$0.0250-Day RangeC$0.02▼C$0.0252-Week RangeC$0.02▼C$0.10Volume4,000 shsAverage Volume52,289 shsMarket CapitalizationC$983,850.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Pascal Biosciences alerts: Email Address Ad Behind the Markets[BUY ALERT] Our #1 A.I. Stock for MarchIt's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.Get the name of the stock here - before it takes off >>> About Pascal Biosciences Stock (CVE:PAS)Pascal Biosciences Inc., a biotechnology company, engages in the research and development of products for the treatment of cancer, and for the improvement of the immune system. The company's development portfolio includes PAS-403, a mitosis inhibitor that blocks cell division for the treatment of glioblastoma and brain metastases originating from other cancers; and PAS-393, an immune-stimulatory cannabinoid designed to restore the immunogenicity of tumor cells with checkpoint inhibitor therapy for use in cancer treatment. It is also developing a B-cell targeted antibody for acute lymphoblastic leukemia and B cell lymphomas; and cannabinoid therapeutic products for the treatment of COVID-19. The company has an exclusive license agreement with the University of Washington to develop a cannabinoid-based product for the treatment of glioblastoma multiforme and brain metastases; and a collaborative research agreement with SoRSE Technology Corporation to advance PAS-393 into clinical testing. Pascal Biosciences Inc. was incorporated in 2011 and is headquartered in Seattle, Washington.Read More PAS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PAS Stock News HeadlinesMarch 27, 2024 | msn.comPedro Pascal Wraps 'The Last Of Us' Season 2 Filming In Record Time: What It Means For Joel's FateMarch 27, 2024 | msn.comThe Last Of Us 2 Fans Mock Pedro Pascal's Short Filming Stint On Season 2March 28, 2024 | Crypto Swap Profits (Ad)Grab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.March 27, 2024 | bbc.co.ukPascal Struijk: Leeds United defender out for season after groin surgeryMarch 27, 2024 | msn.comThe Last of Us Season 2 gets surprising Pedro Pascal updateMarch 27, 2024 | msn.comThe Last Of Us Fans Fear The Worst After Pedro Pascal Filming Update, But I Have A More Optimistic TheoryMarch 27, 2024 | msn.comWhy Pedro Pascal's The Last of Us Schedule Became a Major StoryMarch 26, 2024 | msn.comPascal Siakam helps Pacers pull away from Clippers for 133-116 winMarch 28, 2024 | Crypto Swap Profits (Ad)Grab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.March 25, 2024 | msn.comLeeds United reach Pascal Struijk surgery deadline as potential season-ending decision set for revealMarch 25, 2024 | sportsbookwire.usatoday.comPascal Siakam Player Prop Bets: Pacers vs. Clippers | March 25March 25, 2024 | msn.comPascal Siakam's 36-point paint domination shows how he's changed the Pacers' approachMarch 23, 2024 | msn.comThe Forgotten Pedro Pascal TV Series Role That Saved His Hollywood CareerMarch 22, 2024 | sportsbookwire.usatoday.comPascal Siakam Player Prop Bets: Pacers vs. Warriors | March 22March 20, 2024 | msn.comA Look Back at Everyone’s Favorite Awards Season Faux-Feud: Kieran Culkin and Pedro PascalMarch 19, 2024 | msn.comA Look Back at Everyone's Favorite Awards Season Faux-Feud: Kieran Culkin and Pedro PascalMarch 19, 2024 | sportsbookwire.usatoday.comPascal Siakam Player Prop Bets: Pacers vs. Cavaliers | March 18March 19, 2024 | yahoo.comPedro Pascal Reveals Just How Important Buffy the Vampire Slayer Was to His CareerMarch 19, 2024 | msn.comPedro Pascal Says ‘Buffy the Vampire Slayer’ Residual Check Saved Him From Quitting Acting | VideoMarch 19, 2024 | msn.comPedro Pascal Reflects on the Role ‘Buffy the Vampire Slayer’ Played in Sustaining His Early Acting CareerMarch 18, 2024 | msn.comMyles Turner and Pascal Siakam earn more Player of the Week nominations for PacersMarch 18, 2024 | msn.comWho Are Pedro Pascal's 3 Siblings? Everything to Know About His 2 Sisters and BrotherMarch 18, 2024 | msn.comPedro Pascal Says 'Buffy the Vampire Slayer' Residual Check Saved Him From Quitting Acting | VideoMarch 18, 2024 | msn.comThe Last of Us star Pedro Pascal says his Buffy role saved him from becoming homelessMarch 18, 2024 | msn.comPedro Pascal Had $7 to His Name When This TV Role Saved HimMarch 18, 2024 | msn.comPedro Pascal’s 60s-Style MCU Costume Is Brought To Life In Brilliant Fantastic Four ArtMarch 17, 2024 | msn.comThe Last of Us’s Pedro Pascal says Buffy role saved him from being homelessSee More Headlines Receive PAS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pascal Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:PAS CUSIPN/A CIKN/A Webwww.biommune.net Phone+1-604-6886775FaxN/AEmployees6Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-340.40% Debt Debt-to-Equity Ratio882.79 Current Ratio0.03 Quick Ratio0.17 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$0.00 per share Price / Cash Flow55.00 Book ValueC($0.02) per share Price / Book-0.75Miscellaneous Outstanding Shares65,590,000Free FloatN/AMarket CapC$983,850.00 OptionableNot Optionable Beta1.51 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Harold H. Forzley C.A. (Age 69)Chief Financial Officer Comp: $16.8kDr. Brian W. Bapty Ph.D. (Age 53)CEO, Pres & Director Mr. Kevin M. Egan M.B.A.Chief Bus. OfficerKey CompetitorsiCo TherapeuticsCVE:ICOCotinga Pharmaceuticals Inc. (COT.V)CVE:COTSolarvest BioEnergyCVE:SVSBioasis TechnologiesCVE:BTIMedifocus Inc. (MFS.V)CVE:MFSView All Competitors PAS Stock Analysis - Frequently Asked Questions How have PAS shares performed in 2024? Pascal Biosciences' stock was trading at C$0.02 on January 1st, 2024. Since then, PAS stock has increased by 0.0% and is now trading at C$0.02. View the best growth stocks for 2024 here. What other stocks do shareholders of Pascal Biosciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Pascal Biosciences investors own include Aurora Cannabis (ACB), Canadian Natural Resources (CNQ), Corus Entertainment (CJR), Auxly Cannabis Group (CBWTF), Grande West Transportation Group (BUS), Bausch Health Companies (BHC), Abattis Bioceuticals (ATT), Algonquin Power & Utilities (AQN), Aphria (APHA) and Abacus Mining & Exploration (AME). How do I buy shares of Pascal Biosciences? Shares of PAS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:PAS) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryMost important medical advance in 100 yearsThe Oxford ClubFed launches fourth dollar overhaulStansberry ResearchBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pascal Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.